Hatsushima-Hakamori Disease

Hatsushima Hakamora is an inherited autosomal recessive disease. It is associated with metabolic disorders and accumulation of polysaccharide in the cell. This occurs due to a gene that is responsible for this process. Patients are usually born with normal physiological signs, but over time begin to exhibit symptoms of the disease, such as enlargement of the liver, spleen and lymph nodes, as well as chronic liver disease.

The causes of Hatsumora-Hakomori disease are as follows - heterozygous carriage of the pathological gene - "hha" - on the maternal side with transmission with a 50% probability from a man, from a mother who is a heterozygote. Heterozygotes do not show clinical signs of pathology.

Treatment for Hatzishima-Hekamori disease includes special diets, medications and other medical treatments. Doctors may also prescribe additional treatments, such as surgery or weight control devices. In severe forms of the disease, patients may require an organ transplant.

Patient treatment strategies